Pharmacy Times had Dr. Debra Goff, our 2021 Leadership Award recipient and member of our Scientific Advisory Council, on their webcast to discuss C. diff Awareness Month, antibiotic stewardship, and the work of PLF.
New York, NY (November 8, 2021)— The Peggy Lillis Foundation (PLF) has kicked off C. diff Awareness Month with a successful gala fundraiser, the launch of a new PSA, a continued goal of having C. diff designated as a Nationally Notifiable Disease, its third annual “See C. diff” campaign, and …
Peggy Lillis Foundation for C. diff Education & Advocacy (PLF), the leading patient organization combating C. difficile infections (CDI), partners with Ferring Pharmaceuticals through a new sponsorship to help fund new and existing patient advocacy initiatives. Joining forces, PLF and Ferring are eager to continue helping people living with CDI …
The Food and Drug Administration (FDA) issued a Safety Alert today Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to COVID-19. According to the alert, “FDA is informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal …
On March 12, the Food and Drug Administration (FDA) issued a safety alert that eight patients were infected following fecal microbiota transplants (FMT) using material from a company which was later confirmed to be OpenBiome, an independent stool bank. Two of the patients subsequently died. FDA did not name OpenBiome …
